163 related articles for article (PubMed ID: 23116145)
1. A cyclometallated iridium(III) complex as a c-myc G-quadruplex stabilizer and down-regulator of c-myc oncogene expression.
Yang H; Ma VP; Chan DS; He HZ; Leung CH; Ma DL
Curr Med Chem; 2013; 20(4):576-82. PubMed ID: 23116145
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
3. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
4. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
[TBL] [Abstract][Full Text] [Related]
6. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
7. Cyclometalated Iridium(III) Imidazole Phenanthroline Complexes as Luminescent and Electrochemiluminescent G-Quadruplex DNA Binders.
Castor KJ; Metera KL; Tefashe UM; Serpell CJ; Mauzeroll J; Sleiman HF
Inorg Chem; 2015 Jul; 54(14):6958-67. PubMed ID: 26125314
[TBL] [Abstract][Full Text] [Related]
8. Ruthenation of Non-stacked Guanines in DNA G-Quadruplex Structures: Enhancement of c-MYC Expression.
Rodríguez J; Mosquera J; Couceiro JR; Vázquez ME; Mascareñas JL
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15615-15618. PubMed ID: 27860057
[TBL] [Abstract][Full Text] [Related]
9. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
[TBL] [Abstract][Full Text] [Related]
10. A highly selective G-quadruplex-based luminescent switch-on probe for the detection of gene deletion.
He HZ; Chan DS; Leung CH; Ma DL
Chem Commun (Camb); 2012 Oct; 48(76):9462-4. PubMed ID: 22692458
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
12. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA.
Peng D; Tan JH; Chen SB; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2010 Dec; 18(23):8235-42. PubMed ID: 21036049
[TBL] [Abstract][Full Text] [Related]
13. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
[TBL] [Abstract][Full Text] [Related]
14. Microwave-assisted synthesis of ruthenium(II) complexes with alkynes as potential inhibitor by selectively recognizing c-myc G-quadruplex DNA.
Zhang S; Wu Q; Zhang H; Wang Q; Wang X; Mei W; Wu X; Zheng W
J Inorg Biochem; 2017 Nov; 176():113-122. PubMed ID: 28888786
[TBL] [Abstract][Full Text] [Related]
15. Targeting G-Rich DNA Structures with Photoreactive Bis-Cyclometallated Iridium(III) Complexes.
Weynand J; Bonnet H; Loiseau F; Ravanat JL; Dejeu J; Defrancq E; Elias B
Chemistry; 2019 Oct; 25(55):12730-12739. PubMed ID: 31290208
[TBL] [Abstract][Full Text] [Related]
16. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
Yin F; Liu J; Deng X; Wang J
J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
[TBL] [Abstract][Full Text] [Related]
17. Ru-indoloquinoline complex as a selective and effective human telomeric G-quadruplex binder.
Yu HJ; Zhao Y; Mo WJ; Hao ZF; Yu L
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():84-90. PubMed ID: 24858349
[TBL] [Abstract][Full Text] [Related]
18. G-quadruplex and duplex DNA binding studies of novel Ruthenium(II) complexes containing ascididemin ligands.
Wumaier M; Shi JJ; Yao TM; Hu XC; Gao RR; Shi S
J Inorg Biochem; 2019 Jul; 196():110681. PubMed ID: 30999223
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
